Drug Halves Tumor Recurrence for Women With a Common Breast Cancer
WEDNESDAY, Dec. 5, 2018 (HealthDay News) — For certain women with early stage breast cancer, a newer drug that combines an antibody with chemotherapy may cut the risk of disease recurrence in half, a new trial finds. The study focused on nearly 1,500 women with early stage breast cancer thatContinue Reading












